Green Coffee Effect on Metabolic Syndrome
Supportive Care, Metabolic Syndrome, Obesity
About this trial
This is an interventional supportive care trial for Supportive Care
Eligibility Criteria
Inclusion Criteria: Participants were enrolled if they were aged 20-60y waist circumference >102 cm in male; 88 cm in female triglycerides ≥150 mg/dL (1.7 mmol/L) HDL-C<40 mg/dL (1.03 mmol/L) in males & <50 mg/dL (1.29 mmol/L) in females systolic BP ≥ 130 or diastolic BP ≥ 85 mm Hg. Exclusion Criteria: liver, kidney, coronary artery disease, type I diabetes, autoimmune diseases, cancer, infection, smoking, recent major surgery, routine coffee consumption, pregnancy or breast-feeding, use of anti-inflammatory drugs, corticosteroids, hormone replacement therapy, weight-loss and anti-hypercholesterolemic medications three months or less prior to enrolment
Sites / Locations
- Naglaa Khedr
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
green been extract treated group
Placebo group
Participants included in the study were maintained on a balanced diet and supplemented with Green Coffee Bean (Coffea Arabica) extract capsules (800 mg/capsule
Participants included in the study were maintained on a balanced diet and supplemented with placebo capsules.